News story from Finanz Nachrichten on Tuesday 23 July 2019
Finanz Nachrichten,
Excellent Preclinical Efficacy Data of Apogenix' HERA-GITRL Published in Journal for ImmunoTherapy of Cancer
Digital Journal,
HERA-GITRL Shows Strong Single-Agent Anti-Tumor Activity in Vitro and in Vivo and is Superior to Bivalent Clinical Benchmark…
Excellent Preclinical Efficacy Data of
Direkt Broker ,
Apogenix' HERA-GITRL Published in Journal for ImmunoTherapy of Cancer HERA-GITRL Shows Strong Single-Agent Anti-Tumor Activity…